AstraZeneca's bucket problem | Lex

Financial Times
Financial Times
  • 5 years ago
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs

AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph and Robert Armstrong discuss, it needs more good news to stem its patent expiration problem.
For more video content from the Financial Times, visit http://www.FT.com/video


Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes

Recommended

4:44
I
Up next
More Women Makes Business Sense - Financial Times Report
Financial Times
2:54
Financial Times Business of Football conference 2013
Financial Times
7:02
John Fallon discusses sale of Financial Times | FT Business
Financial Times
3:20
AstraZeneca's Christmas shopping | Lex
Financial Times
2:55
Tough times for US natural gas | Lex
Financial Times
3:31
Tough times at Anglo American | Lex
Financial Times
3:57
UK Government Faces Tough 2011 - Financial Times Analysis
Financial Times
3:56
Aerobatics In A Pitts Special Biplane - The Financial Times
Financial Times
2:22
Find your next adventure at the Financial Times
Financial Times
2:20
The Financial Times 'FT.com' Site Tour
Financial Times
9:37
White House Responds To Weak Job Numbers - Financial Times
Financial Times
4:24
The Revival Of Rio De Janeiro - Financial Times
Financial Times
4:27
Silicon Roundabout - Hype or Reality? - Financial Times Report
Financial Times
1:51
What makes The 125 different? I Financial Times
Financial Times
4:55
Aston Martin Gets Ready To Rumble - The Financial Times
Financial Times
10:20
China's 'Shock and Awe' & the Arms War Threat - Financial Times Analysis
Financial Times
1:29
Find your next adventure at the Financial Times: My city, La Paz
Financial Times
2:03
Introducing the Financial Times
Financial Times
4:26
Stella McCartney Looks To Generation X - Financial Times
Financial Times
1:28
Financial Times iPhone Application
Financial Times
2:50
Financial Times Live Stream
Financial Times
0:20
Financial Times Fingertips Advert - US Version
Financial Times
6:10
Angry Birds maker hails shift to Mobile - Financial Times
Financial Times
5:25
The battle for the Olympic Stadium - Financial Times
Financial Times
4:37
Why US Manufacturing Can Take On China - Financial Times Analysis
Financial Times
1:17
BEHIND THE NUMBERS - AstraZeneca aims for sales of $80 billion by 2030
MarketScreener
1:07
LE CHIFFRE - 80 milliards de dollars, le chiffre d'affaires qu'AstraZeneca veut atteindre en 2030
Zonebourse
4:42
New research examines blood clot risks with AstraZeneca COVID-19 vaccine
ABC NEWS (Australia)
1:46
AstraZeneca COVID-19 Vaccine Linked To Another Rare Fatal Blood Clotting Disorder VITT
LatestLY
1:22:48
Ukraine ; AstraZeneca ; De la diversité au séparatisme
Sud Radio
19:16
COVID : AstraZeneca retire son vaccin du marché.
Sud Radio

Financial Times

2:31
EU leaders offer the UK a six-month Brexit delay
Financial Times
1:11
ECB keeps monetary policy unchanged
Financial Times
1:59
Theresa May granted Brexit delay until end of October
Financial Times
12:28
Crunched: philanthropy versus tax avoidance
Financial Times
1:39
How scientists took first picture of a black hole
Financial Times
0:56
Theresa May arrives in Brussels seeking Brexit delay
Financial Times

Featured channels

More from
Met Office
More from
ODN
More from
SWNS
More from
GoodtoKnow
More from
Evening Standard
More from
FourFourTwo